Brief: Eagle Pharmaceuticals Wins Vasopressin Patent Trial
Aug 31 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS WINS VASOPRESSIN PATENT TRIAL
* EAGLE - U.S. DISTRICT COURT FOR DISTRICT OF DELAWARE HELD THAT CO'S
PROPOSED
VASOPRESSIN PRODUCT DOES NOT INFRINGE ANY OF PATENTS PAR ASSERTED AGAINST CO
Source text for Eikon: ID:nBwF6HBYa
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq